Navigation Links
Can't Stop Eating M&Ms?
Date:9/20/2012

By Steven Reinberg
HealthDay Reporter

THURSDAY, Sept. 20 (HealthDay News) -- Scientists served M&Ms to rats in an experiment that showed the brain can't resist sweet and fatty foods.

The University of Michigan researchers said the urge to overeat tasty treats comes from an unexpected area of the brain called the neostriatum, which produces an opium-like chemical that enhances such desire and may be partly responsible for overeating among people.

"Previously, people thought this area of the brain was only involved in motor function and learning, but we found it's involved in motivation and generating instant consumption," said lead researcher Alexandra DiFeliceantonio, a graduate student in biopsychology at the university.

This finding might have implications for people, she added, noting that it may be possible in the future to target the area with a drug that could block the impulse to overeat and thus may help people lose weight.

Experts note, however, that results in animal studies often don't translate to humans.

The new report was published Sept. 20 in the journal Current Biology.

For the study, DiFeliceantonio and her colleagues gave lab rats a drug to artificially boost the action of the neostriatum. The animals were then given M&Ms, and proceeded to eat twice as many as they normally would, she said.

"That's the same as a 150-pound human eating seven pounds of M&Ms in an hour," DiFeliceantonio said.

In addition, the researchers noted that the amount of a chemical called enkephalin, produced in the neostriatum, increased when the animals ate the chocolate treats.

It is the increased production of this chemical that increases the desire to overeat sweet and fatty foods, DiFeliceantonio said. When presented with a choice of usual food or M&Ms, the rats with high levels of the chemical consistently ignored their regular food and gorged on choco
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Only children are significantly more likely to be overweight
2. Marital status, race increase survival rate significantly for Stage III non-small cell lung cancer patients
3. Non-invasive diagnostic imaging costs to Medicare Part B down significantly since 2006
4. Circumcision Benefits Are Significant, Pediatricians Say
5. Renal denervation achieves significant and sustained blood pressure reduction
6. Diagnostic test shows potential to noninvasively identify significant coronary artery disease
7. FDA Cites Possible Source of Cantaloupe-Salmonella Outbreak
8. Research presented at TCT 2012 will have significant impact on interventional cardiology
9. Study: Vaccine targets malignant brain cancer antigens, significantly lengthens survival
10. Greening Vacant Lots May Boost Safety
11. Penn study finds with vacant lots greened, residents feel safer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Can't Stop Eating M&Ms?  
(Date:5/28/2015)... (PRWEB) May 28, 2015 Real Time ... lotion and products, today announced their best-selling lotion is now ... Time Pain Relief is an FDA registered OTC pain relief ... herbal ingredients, such as Aloe Vera, Arnica, Capsicum, Chondroitin, Emu ... level of Menthol – only 1.25% – to avoid buildup ...
(Date:5/28/2015)... May 28, 2015 Hexagon Geospatial is ... , a provider of engineering, spatial data and mapping ... analyze thousands of point clouds for urban change assessments ... to 2014, the BHI Spatial Data Division implemented a ... stereo aerial imagery. Collected by a variety of different ...
(Date:5/28/2015)... IL (PRWEB) May 28, 2015 Cancer ... program exhibited improvements in physical activity, fitness and quality ... Irwin of Yale Cancer Center and Jennifer Ligibel, MD, ... Women’s Cancers, Dana Farber Cancer Institute. The findings will ... Clinical Oncology (ASCO) Annual Meeting in Chicago. ...
(Date:5/28/2015)... May 28, 2015 The MIT Sloan ... study featuring Healthcare IQ. Members of the MIT CISR ... management team to develop the case study about Healthcare ... analytics. , The case study, ‘Healthcare IQ: Competing as ... from its beginning as a hospital financial software provider ...
(Date:5/28/2015)... Dallas urologist Mark Allen, MD has ... education website NORTHTEXASUROLOGIST.COM developed by eMedical ... access current educational information on various urological concerns ... prostate cancer treatment, robotic surgery and female urinary ... educate patients on urological conditions and treatments, enabling ...
Breaking Medicine News(10 mins):Health News:Real Time Pain Relief Introduces New Four Ounce Pump Bottle for their Popular Pain Relief Lotion 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 2Health News:Hexagon Geospatial Supports Urban Change Detection Programs in New Mexico 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 4Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 2Health News:Healthcare IQ, the “Switzerland” of Healthcare Spend Analytics, Featured in MIT Case Study 3Health News:Mark Allen MD, Dallas Urologist, Launches Updated Patient Education Website With a Focus on Prostate Cancer and Erectile Dysfunction Treatment 2
... embarks on one of its top priorities--reforming the nation,s health care ... of Health Care Reform, which will be announced during a media ... , ... Washington, DC (Vocus) February 6, 2009 -- As ...
... The Pink Frister on The Pacific Edge is set for ... Lucy, CEO of Code Pink Boot Camp, is pleased to ... event benefiting Fristers, a non-profit that supports teen and young ... 28 at 4:00pm at the Pacific Edge Hotel in Laguna ...
... "Psoriasis Cure Now," a nonprofit patient advocacy organization, ... help everyday Americans interested in medical research be heard ... powerful lobbyists and special interests. The Web site ... make biomedical research a meaningful part of any stimulus ...
... whether people were scanned or not , , FRIDAY, Feb. 6 ... low back pain that has no apparent underlying cause doesn,t ... that doctors should not conduct routine MRI, CT or radiography ... authors say. , Dr. Roger Chou, of the Oregon Health ...
... skepticism correlate with lower cancer screening rates , , FRIDAY, ... women, have more distrust of the medical system, which ... research shows. , Almost half of all women agreed ... health-care organizations." Eighteen percent strongly agreed with the statement. ...
... Institute for Palliative Medicine,s Fellowship Program received full accreditation ... -- the first accredited fellowship program in palliative medicine ... Diego Hospice, The Institute for Palliative Medicine has trained ... Medicine is known as one of the most clinically ...
Cached Medicine News:Health News:Pharmacy Stakeholder Groups Collaborate to Draft Pharmacy Principles for Health Care Reform 2Health News:Pharmacy Stakeholder Groups Collaborate to Draft Pharmacy Principles for Health Care Reform 3Health News:Code Pink Boot Camp Supports Fristers and Young Mothers 2Health News:Psoriasis Cure Now launches StimulateResearch.com to Ensure That Medical Research is Part of Stimulus Bill 2Health News:Imaging of Low Back Pain Fails to Change Outcomes 2Health News:Minorities Distrust Medical System More 2Health News:Minorities Distrust Medical System More 3Health News:San Diego Medical Community Receives First-Ever Accredited Palliative Medicine Fellowship Program 2Health News:San Diego Medical Community Receives First-Ever Accredited Palliative Medicine Fellowship Program 3
(Date:5/28/2015)... 26, 2015 Research and Markets( http://www.researchandmarkets.com/research/rjpc7h/2015_strategies ... "2015 Strategies in the US Ancillary Hospital Locations ... to their offering. This new 973-page ... of the diagnostic testing markets outside the main ... includes analysis of the market dynamics, size, growth, ...
(Date:5/28/2015)... May 28, 2015  Freedom Meditech, Inc., a medical ... diseases from current blood-based standards to early and non-invasive ... million in a Series C financing. The company seeks ... million since founded. The company has also appointed Mr. ... a member of the company,s board of directors. Mr. ...
(Date:5/28/2015)... , May 28, 2015  According to Kalorama Information, ... Omnicare for approximately $12.7 billion fits a prevailing trend ... from an aging population. The U.S. long term care ... to continue as the aging population increases demand for ... The healthcare market researcher,s report, The Long Term ...
Breaking Medicine Technology:Strategies in the US Ancillary Hospital Locations (ERs, ORs, ICUs) Diagnostic Testing Market 2015-2020 2Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 2Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 3Freedom Meditech Raises $4.8 Million and Appoints John Gerace as Chief Executive Officer 4Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 2Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 3Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 4
... - Millennium on track to file sNDA in ... 18 Millennium,Pharmaceuticals, Inc. (Nasdaq: MLNM ) ... large, international Phase III VISTA(1) trial in,patients with ... of,VELCADE, melphalan and prednisone (VMP) demonstrated a highly ...
... 10 minutes - - Landmark Study Reported in ... 18 A landmark publication that,appeared in the Journal ... site blinded clinical study. The paper is entitled "The ... Accuracy of,Melanoma and Equivocal Melanocytic Lesions." The study, ...
Cached Medicine Technology:Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 2Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 3Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 4Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 5Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints 6Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy 2Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy 3
Straight shafts with micro Pierse type tips. Flat open serrated handle, dull finish....
Curved shafts with 0.5 mm, 1 x 2 teeth. Serrated handle with thumb catch lock and polished finish....
Jaws with fine teeth. Serrated handle with polished finish. Jaws: Wide, 4.5 mm. With thumb catch lock....
Straight shafts with curved 1 x 2 teeth. Serrated handle with polished finish....
Medicine Products: